Pharmacokinetics of lidocaine and its metabolite in peridural anesthesia administered to pregnant women with gestational diabetes mellitus

European Journal of Clinical Pharmacology

Volumn 64, Issue 12, 2008, Pages 1189-1196

  Moisés, Elaine Christine Dantas ^a   Duarte, Luciana De Barros ^a   Cavalli, Ricardo De Carvalho ^a   Marques, Maria Paula ^a   Lanchote, Vera Lúcia ^a   Duarte, Geraldo ^a   Da Cunha, Sérgio Pereira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epidural route; Gestational diabetes mellitus; Lidocaine; MEGX; Monoethylglycinexylidide; Obstetrical anesthesia; Pharmacokinetics; Pregnancy

Indexed keywords

DEETHYLLIDOCAINE; LIDOCAINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; EPIDURAL ANESTHESIA; FEMALE; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; MAXIMUM PLASMA CONCENTRATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 57049152999     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0544-0     Document Type: Article

References (31)

1. KGMM Alberti PZ Zimmet 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation Diabet Med 15 539 553
2. MJ Bargetzi T Aoyama FJ Gonzalez UA Meyer 1989 Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4 Clin Pharmacol Therap 46 521 527
3. Bernards CM (2001) Epidural and spinal anesthesia. In: Barash PG, Cullen BF, Stoelting RK (eds) Clinical anesthesia, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1-43
4. DP Braid DB Scott 1966 Dosage of lignocaine in epidural block in relation to toxicity Br J Anaesth 38 596 602
5. RC Cavalli VL Lanchote G Duarte ECD Moisés MFM Prado LB Duarte SP Cunha 2004 Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women Eur J Clin Pharmacol 60 569 574
6. PY Cheng ET Morgan 2001 Hepatic cytochrome P450 regulation in disease states Curr Drug Metab 2 165 183
7. JW Downing HV Johnson HF Gonzalez TL Arney NL Herman RF Johnson 1997 The pharmacokinetics of epidural lidocaine and bupivacaine during cesarean section Anesth Analg 84 527 532
8. Emami J, Passutto FM, Jamali F (1998) Effect of experimental diabetes mellitus and arthritis on the pharmacokinetics of hydroxychloroquine enantiomers in rats 15(6):897-903
9. Gilman GA, Hardman JG, Limbird LE (2001) Goodman and Gilman's the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York
10. R Hodgkinson FJ Husain 1980 Obesity and cephalad spread of analgesia following epidural administration of bupivacaine for cesarean section Anesth Analg 59 89 92
11. H Iber T Li-Masters Q Chen S Yu ET Morgan 2001 Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting and inflammation J Pharmacol Exp Therap 297 174 180
12. MH Isohanni PJ Neuronen VJ Palkama KT Olkkola 1998 Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine Eur J Clin Pharmacol 54 561 565
13. KT Kivisto HK Kroemer 1997 Use of probe drugs as predictors of drug metabolism in humans J Clin Pharmacol 37 1 Suppl S40 S48
14. BB Little 1999 Pharmacokinetics during pregnancy: evidence-based maternal dose formulation Obstet Gynecol 93 858 868
15. MP Marques EB Coelho NA Dos Santos TJ Geleilete VL Lanchote 2002 Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus Eur J Clin Pharmacol 58 607 614
16. S Nattel G Gagne M Pineau 1987 The pharmacokinetics of lignocaine and b-adrenoreceptor antagonists in patients with acute myocardial infarction Clinl Pharmacokinet 13 293 316
17. R Orlando P Piccoli S De Martin R Padrini P Palatini 2003 Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function Br J Clin Pharmacol 55 86 93
18. RA Preston M Chung M Gaffney A Alonso NM Baltodano M Epstein 2001 Comparative pharmacokinetics and pharmacodynamics of amlodipine in hypertensive patients with and without type II diabetes mellitus J Clin Pharmacol 41 1215 1224
19. RA Preston M Epstein 1999 Effects of diabetes on cardiovascular drug metabolism. Emerging clinical implications Diabetes Care 22 982 988
20. J Ramanathan M Bottorff JN Jeter M Khalil BM Sibai 1986 The pharmacokinetics and maternal and neonatal effects of epidural lidocaine in preeclampsia Anesth Analg 65 120 126
21. F Reynolds C Taylor 1970 Maternal and neonatal blood concentrations of bupivacaine: a comparison with lignocaine during continuous epidural analgesia Anesthesia 25 14 23
22. JB Schenkman 1991 Induction of diabetes and evaluation of diabetic state on P450 expression Methods Enzymol 206 325 331
23. N Shimojo 1994 Cytochrome P450 changes in rats with streptozotocin- induced diabetes Int J Biochem 26 1261 1268
24. EA Sotaniemi A Rautio M Bäckstron P Arvela O Pelkonen 1995 CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients Br J Clin Pharmacol 39 71 76
25. Sweetman SC (2002) Martindale: the complete drug reference, 33rd edn. Pharmaceutical Press, London
26. JS Wang JT Backman X Wen P Taavitsainen PJ Neuvonen KT Kivisto 1995 Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro Pharmacol Toxicol 85 201 205
27. JS Wang JT Backman P Taavitsainen PJ Neuvonen KT Kivisto 2000 Involvement of CYP1A2 and CYP3A4 in lidocaine n-deethylation and 3-hydroxylation in humans Drug Metab Disp 25 959 965
28. JA Wildsmith C Strichartz 1984 Local anaesthetic drugs - an historical perspective Br J Anaesth 56 937 939
29. SN Wildt GL Kearns JS Leeder JN Van den Anker 1999 Cytochrome P450 3A. Ontogeny and drug disposition Clin Pharmacokinet 37 485 505
30. KJ Woodcroft RF Novak 1999 Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes J Pharmacol Exp Therap 289 1121 1127
31. KJ Woodcroft RF Novak 1999 The role of phosphatidylinositol 3-kinase, Src kinase, and protein kinase A signaling pathways in insulin and glucagon regulation of CYP2E1 expression Biochem Biophys Res Comm 266 304 307